Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 2/20 | 0.73 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.73 |
| ▸ | LCK known ✓ | P06239 | 1/20 | 0.73 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.73 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.73 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.47 |
| ▸ | PPARG known ✓ | P37231 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 6/20 | 0.73 |
| ▸ | USP2 | O75604 | 3/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.73 |
| ▸ | RECQL | P46063 | 2/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | FYN | P06241 | 1/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.73 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 3/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7872034 | 1.00 | SLC7A5 (0.73) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL5108518 | 0.98 | SLC7A5 (0.71) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL29405664 | 0.98 | SLC7A5 (0.75) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL180009 | 0.98 | SLC7A5 (0.75) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL180010 | 0.98 | SLC7A5 (0.75) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL16826246 | 0.98 | SLC7A5 (0.75) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL29622702 | 0.98 | SLC7A5 (0.75) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Water SCHEMBL7731937 | 0.97 | SLC7A5 (0.73) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Water SCHEMBL16816917 | 0.94 | SLC7A5 (0.69) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Tyrosine SCHEMBL18301523 | 0.92 | SLC7A5 (0.73) | SLC7A5USP2PTGS1KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120021004-A1 | MEDIUM AND METHOD OF DERIVING AND USING A MUTATED BACTERIA STRAIN | PARKER JILL E (US) | 2012-01-26 | — | — | US | claimed |
| US-8092988-B1 | Medium and method of deriving and using a mutated bacteria strain | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2012-01-10 | — | — | US | claimed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| US-8628955-B2 | Compositions, methods and uses for biosynthetic plasmid integrated capture elements | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE, THE | 2014-01-14 | — | — | US | disclosed |
| US-20130040305-A1 | COMPOSITIONS, METHODS AND USES FOR BIOSYNTHETIC PLASMID INTEGRATED CAPTURE ELEMENTS | KIEL JOHNATHAN L (US) | 2013-02-14 | — | — | US | disclosed |
| US-20120021004-A1 | MEDIUM AND METHOD OF DERIVING AND USING A MUTATED BACTERIA STRAIN | PARKER JILL E (US) | 2012-01-26 | — | — | US | disclosed |
| US-8092988-B1 | Medium and method of deriving and using a mutated bacteria strain | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2012-01-10 | — | — | US | disclosed |
| US-20110027851-A1 | COMPOSITIONS, METHODS AND USES FOR BIOSYNTHETIC PLASMID INTEGRATED CAPTURE ELEMENTS | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE, THE | 2011-02-03 | — | — | US | disclosed |
| US-7279320-B1 | Curlicue vaccine strain of Bacillus anthracis | UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2007-10-09 | — | — | US | disclosed |
| EP-0276631-B1 | WETTABLE SURFACE MODIFIED CONTACT LENS FABRICATED FROM AN OXIRANE CONTAINING HYDROPHOBIC POLYMER | CIBA-GEIGY AG (CH) | 1991-05-29 | — | — | EP | disclosed |
| EP-0276631-A1 | Wettable surface modified contact lens fabricated from an oxirane containing hydrophobic polymer | CIBA-GEIGY AG (CH) | 1988-08-03 | — | — | EP | disclosed |
| US-4734475-A | Wettable surface modified contact lens fabricated from an oxirane containing hydrophobic polymer | CIBA-GEIGY CORPORATION (US) | 1988-03-29 | — | — | US | disclosed |